Dante Labs Issued Genomic Medical Laboratory Authorization in Dubai

Dubai Lab

Dante Lab in Dubai

NEW YORK, Feb. 14, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, is pleased to announce that on January 19, 2022, the Dante Labs Sequencing Center in Dubai was issued a license as a authorized medical laboratory for genomics.

This new license authorizes operations in the following areas:

  • Clinical Cytogenetics
  • Clinical Pathology
  • Laboratory Allied Healthcare
  • Clinical Genetics
  • Cytogenetics
  • Medical Genetics

“This medical authorization is an important stepping stone to deliver advanced genomic solutions in the UAE, to the Middle East’s 400 million residents and beyond,” said Andrea Riposati, CEO of Dante Labs. “The UAE is clearly becoming a global leader in genomics, and we are extremely excited to have invested in this amazing country.”

Dante Labs built a state-of-the-art genomic sequencing laboratory of more than 1200 sq mt in the Dubai Silicon Oasis.

“This authorization is a recognition of the hard work by the local Dante Labs team,” said Dr. Mattia Capulli, Chief Scientific Officer of Dante Labs. “We are now very keen to develop clinical solutions for the entire region and the rest of the world.”

About Dante Labs

Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contacts

Giorgio Lodi
media@dantelabs.com
+39 0862 191 0671
www.dantelabs.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/93a78f46-a0b0-420a-aecf-e97b27247b51

Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

MOSCOW, Feb. 14, 2022 /PRNewswire/ — The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca’s vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite).

The Russian Direct Invest Fund (RDIF) Logo

According to the interim results of the trials, involving 100 volunteers in Russia and 100 volunteers in Azerbaijan, the vaccines combination demonstrated an acceptable safety profile, which is consistent with the results of previous AstraZeneca vaccine, Sputnik V and Sputnik Lite vaccines clinical trials.

Volunteers were being monitored for 57 days after the first dose. Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered.

The research conducted by RDIF, the Gamaleya Center, AstraZeneca, and R-Pharm is the first study in the world to evaluate the combined use of components of different adenovirus vaccines to prevent coronavirus infection. In December 2021, the World Health Organization (WHO) recommended a similar approach, also known as heterologous prime booster vaccination.[i] The WHO estimates that interchangeability of different drugs will allow greater flexibility in vaccination programs, increase vaccine efficacy and affordability.

A joint phase II clinical trial to evaluate the safety and immunogenicity of a combination of AstraZeneca’s vaccine and the first component of the Sputnik V vaccine is being conducted under the memorandum signed in December 2020 by the Russian Direct Investment Fund, the Gamaleya Center, AstraZeneca and R-Pharm. The study takes place in Azerbaijan, Russia and the United Arab Emirates. Volunteers receive intramuscular injections of the AstraZeneca vaccine and the Ad26-S component of the Sputnik V vaccine in different sequences at 28-day intervals.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF): Preliminary data from the trial to test Sputnik Light and AstraZeneca vaccines combination support the “mix and match” approach to revaccination. With new dangerous variants of concern emerging, this approach could provide safe, effective and long-term protection.

Vasily Ignatiev, CEO of the R-Pharm Group JSC: Current safety data adds to the data on the high immunogenicity profile of the vaccine combination that has been announced earlier. We are one step closer to completing the studies. The results are being processed.

Irina Panarina, GM, Russia & Eurasia: The results, obtained in the clinical trials, indicate the safety of vaccine combination. The use of «vaccine cocktails» may be an option in face of growing healthcare system needs to vaccinate population across the world».

About the Sputnik Light vaccine:

Sputnik Light is based on recombinant human adenovirus serotype number 26 (the first component of Sputnik V). A one-shot vaccination regimen of Sputnik Light provides for ease of administration and helps to increase efficacy and duration of other vaccines when used as a booster shot.

Sputnik Light as a booster significantly increases virus-neutralizing activity against Omicron, which is comparable to titers observed after Sputnik V against wild-type virus, associated with high levels of protection. Sputnik Light has been registered in more than 30 countries with total population of over 2.5 billion people. A number of countries, including Argentina, Bahrain, UAE, San Marino and Philippines, have already authorized Sputnik Light as a universal booster.

About COVID-19 vaccine AstraZeneca

The vaccine was co-invented by the University of Oxford and its spin-out company, Vaccitech. It uses a replication-deficient viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.

[i] World Health Organization. (‎2021)‎. Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021

Logo – https://mma.prnewswire.com/media/1698158/Russian_Direct_Invest_Fund_Logo.jpg

Transaction of 17,735,883 shares of Azgard Nine Limited

Karachi, Azgard Nine Limited informed Pakistan Stock Exchange about transaction of shares of the company. 17,735,883 shares @ Rs. 0.00 per share were gift-in the market on February 11, 2022 through CDC.

The Company was incorporated in Pakistan on January 20, 1993, like a public limited company under the name ‘Indigo Denim Mills Limited’ and obtained a Certificate for Commencement of Business on January 27, 1994. The name was changed to ‘Legler-Nafees Denim Mills Limited’ on 28-02-1994 and subsequently to the present name i.e. ‘Azgard Nine Limited’ on April 07, 2004.

The Principal activities of the Company is composite Spinning, weaving dyeing and stitching unit engaged in the manufacturing of yarn, denim and denim products.

The company is listed on Pakistan Stock Exchange, and also the shares of it are quoted using “ANL” as symbol.

The total number of shares the company has issued are 485,409,731. Earnings Per Share has decreased in 2020 and is (0.84) compared to 0.67 in 2019. The Profit After Taxation in 2020 has also decreased and is (389,449,000) which was 305,312,000 in 2019.

Annual general meeting of Faran Sugar Mills Limited to be held on January 27, 2022

Karachi, Faran Sugar Mills Limited informed Pakistan Stock Exchange that annual general meeting of the company was held on January 27, 2022 at Karachi.

The agenda of the meeting will be confirming the minutes of Annual General Meeting held on February 24, 2021, to receive, consider and adopt the Annual Audited Financial Statements of the Company for the year ended September 30, 2021 together with the Directors and Auditors Reports thereon, to appoint auditors for the year ending September 30, 2022 and fix their remuneration and to transact any other business with the permission of the chair.

Faran Sugar Mills Limited was incorporated in Pakistan on November 03, 1981 as a public limited company. The principal business of the Company is the production and sale of white sugar. The total number of shares of the Company are 25,007,151. The Earnings per share is (6.85) in 2020 which was 15.21 in 2019. The Profit after Taxation of the Company is Rs. (171,317,000) in 2020 which was 380,445,000 in 2019.

Transmission of Quarterly Report for the Period Ended December 31, 2021 of Shakarganj Mills Limited

Karachi, Shakarganj Mills Limited informed Pakistan Stock Exchange that Quarterly Report of the Company for the period ended December 31, 2021 have been transmitted through PUCARS and is also available on Company’s website.

Shakarganj Limited is a public limited company incorporated on 20 September 1967 in Pakistan. It is principally engaged in manufacture, purchase and sale of sugar, biofuel and yarn.

They transform renewable crops such as sugarcane and cotton into value added products comprising of refined sugar, textiles, and bio fuels as well as building materials and generate bio-power from bio-gas which is supplied to the national grid.

The Company have two manufacturing facilities in the Jhang District while our registered head office is in Lahore. Shakarganj Limited also holds a controlling interest in Shakarganj Food Products Limited (SFPL) which is a producer of dairy and fruit products and has since 2006 become a household name in Pakistan.

The total number of shares are 125,000,000. The Earnings per share is (7.98) in 2020 which was (5.83) in 2019. The Company had a loss of Rs. 997,583,000 in 2020 which was 728,411,000 in 2019.

Annual general meeting of Leather Up Limited to be held on March 08, 2022

Karachi, Leather Up Limited informed Pakistan Stock Exchange that annual general meeting of the company is scheduled to be held on March 08, 2022 at Karachi.

The agenda of the meeting will be confirming the minutes of Annual General Meeting held on October 27, 2020, to receive, consider and adopt the Annual Audited Financial Statements of the Company for the year ended June 30, 2021 together with the Directors and Auditors Reports thereon, to appoint auditors for the year ending June 30, 2022 and fix their remuneration and to transact any other business with the permission of the chair.

Further, the closed period of the company is from March 02, 2022 to March 08, 2022 (both days inclusive).

Leather Up Limited was incorporated as a private limited company. Subsequently the Company was converted into a public limited Company on May 15, 1993. The Company is engaged in the manufacture and export of leather garment products.

The total numbers of shares are 6,000,000. The Earnings per share is (0.14) in 2020 which was (1.42) in 2019. The Company had a loss of 860,000 which was 8,195,000.

Non-Holding Annual general meeting of Sakrand Sugar Mills Limited

Karachi, Sakrand Sugar Mills Limited informed Pakistan Stock Exchange that they are still unable to hold the annual general meeting of the company and submit the related Annual Audited Accounts for the year ended September 30, 2021 even within the extended time.

Sakrand Sugar Mills Limited was incorporated in Pakistan as a Public Limited Company on March 02, 1989. The principal business of the company is to manufacture and sell white sugar.

The company is listed on Pakistan Stock Exchange and the total numbers of shares of the Company are 44,616,000. The Earnings per shares of the Company was (13.43) in 2020 which was 3.51 in 2019. Their Profit after Tax was (599,246,000) in 2020 which was 156,649,000 in 2019.

Appointment of Directors of Orix Modaraba

Karachi, Orix Modaraba informed Pakistan Stock Exchange that Ms. Aseya Qasim has been appointed as Director of the company with effect from February 08, 2022 in place of Ms. Maryam Aziz.

ORIX Modaraba was formed and managed by ORIX Services Pakistan (Private) Limited. The Modaraba is a perpetual Modaraba and is primarily engaged in financing of plant and machinery, motor vehicles both commercial and private, computer equipment and housing under the modes of Ijarah Islamic leasing and Diminishing Musharika. The Modaraba may also invest in commercial and industrial ventures suitable for the Modaraba. The Modaraba may also invest in commercial and industrial ventures suitable for the Modaraba.

The total numbers of shares are 45,383,530. The Earnings per share is 2.81 in 2020 which was 2.78 in 2019. The Profit After Taxation is 127,458,000 in 2020 which was 126,057,000 in 2019.

Progress Report of Drekkar Kingsway Limited

Karachi, Drekkar Kingsway Limited informed Pakistan Stock Exchange that to step forward the implementation of revival plan, the Company has commenced the trading activities of the Energy Products. Moreover, the Company is in the process to get the updated Auditors’ Opinion on “Going Concern Assumption” and thereby removing reasons (under Regulation 5.11.1 (b) and (i) of the PSX Regulations) of the defaulters’ counter.

Drekkar Kingsway Limited was registered on June 28, 1993 as Private Limited Company and was subsequently converted into Public Limited Company as on June 29, 1994. The principal activity of the company was manufacturing of all type of electrical appliances, cosmetics, toiletries, leather goods, machinery, components and parts.

In 1996, the company sold its plant and machinery. The company is currently engaged in making equity investments in undervalued profitable situations.

The total numbers of shares are 10,000,000. The (0.68) in 2020 which was (0.07) in 2019. The Company had a loss of Rs. 6,809,000 in 2020 which was 716,000 in 2019.

Annual general meeting of Fauji Foods Limited to be held on March 16, 2022

Karachi, Fauji Foods Limited informed Pakistan Stock Exchange that annual general meeting of the company to be held on March 16, 2022 at Karachi.

The agenda of the meeting will be confirming the minutes of Annual General Meeting held on November 26, 2021, to receive, consider and adopt the Annual Audited Financial Statements of the Company for the year ended December 31, 2021 together with the Directors and Auditors Reports thereon, to appoint auditors for the year ending December 31, 2022 and fix their remuneration and to transact any other business with the permission of the chair.

Further, the closed period of the company is from March 10, 2022 to March 16, 2022 (both days inclusive).

Fauji Foods Limited was incorporated in Pakistan on 26 September 1966 as a Public Company. The company is the subsidiary of Fauji Fertilizer bin Qasim Limited. It is principally engaged in processing and sale of toned milk, milk powder, fruit juices, allied dairy and food products.

The total numbers of shares are 803,293,563. The Earnings per share is (4.62) in 2020 which was (10.74) in 2019. The Company had a loss of Rs. 3,058,112,000 in 2020 which was 5,788,937,000 in 2019.

Corporate Briefing Session of KSB Pumps Company Limited

Karachi, KSB Pumps Company Limited informed Pakistan Stock Exchange that the corporate briefing session of the Company will be held on February 23, 2022 through video link, to brief the analysts/investors/shareholders about the company’s financial performance and future outlook.

KSB Pumps Company Limited was incorporated in Pakistan on July 18, 1959. The Company is a subsidiary of KSB SE & Co. KGaA. It is principally engaged in the manufacture and sale of industrial pumps, valves, castings and related parts and provision of aftermarket services.

KSB Pumps Company Limited specializes in pumps, valves and systems for industrial, building services, energy and water applications. KSB Pumps Company Limited has its Head Office based in Lahore, a manufacturing facility at Hassanabdal with, sales houses in Lahore, Karachi, Multan, and Rawalpindi.

The total number of shares of the Company are 13,200,000. The Earnings per shares of the Company is 1.24 in 2020 which was (6.66) in 2019. Their Profit after tax in 2020 is 16,383,000 which was 87,880,000 in 2019.

Approval of Extension in Time for Holding the Annual General Meeting of Abdullah Shah Ghazi Sugar Mills Limited

Karachi, Abdullah Shah Ghazi Sugar Mills Limited informed Pakistan Stock Exchange that the Securities and Exchange Commission of Pakistan, has approved extension in time for holding Annual General Meeting for the year ended September 30, 2021, up to March 14, 2022, i.e. for 15 days.

Abdullah Shah Ghazi Sugar Mills Limited was incorporated in Pakistan on February 25, 1984 as a Private Limited Company and was subsequently converted into a Public Limited Company on February 11, 1990. The principal business of the company is manufacturing and selling of refined sugar and by products.

Abdullah Shah Ghazi Sugar Mills Ltd was acquired by Macca Group (“Group”) in March 2008. The Group commenced its commercial operations in 1965 and is primarily involved in sugar and molasses manufacturing and import & trading of sugar plants machinery.

The Company has long been working under a Toll Manufacturing agreement with Dewan Sugar Mills Limited. The Macca Group Management has terminated the Toll Manufacturing Agreement and now the company is working independently as a unit.

The total numbers of shares are 79,261,700. The Earnings per share is (2.64) in 2020 which was (0.68) in 2019. The Company had a loss of Rs. 209,298,000 in 2020 which was 54,022,000 in 2019.